Babson Diagnostics hires Jim Donnelly as Chief Scientific Officer & VP Laboratory Operations

AUSTIN, TEXAS, November 5, 2018—Babson Diagnostics, Inc., a healthcare technology company focused on moving laboratory testing to the pharmacy counter, has hired Jim Donnelly as its Chief Scientific Officer and Vice President of Laboratory Operations.  Jim will be responsible for the company’s clinical laboratory operations and R&D.

Jim is an accomplished scientific officer in the diagnostics industry.  Jim worked at Siemens Healthineers’ Diagnostics division from 2007-2016, where he served as Chief Scientific Officer and Global VP for the division’s Medical, Clinical, Scientific, and Statistical Affairs groups.  He served as EVP Regulatory and Clinical Affairs for Quotient Limited from 2016-2018.

Prior to working in the IVD industry, Jim was an accomplished laboratory director and academic researcher.  Jim was Associate Professor of Pathology at NYU School of Medicine and Associate Director of Laboratory Medicine and Pathology at New York City Health and Hospitals Corporation.  In New York City, he was the Medical Director for multiple clinical pathology disciplines and CLIA high complexity laboratories across Manhattan and the Bronx.

Jim completed his Ph.D. in Pharmacology and Biochemistry at The George Washington University and his MBA from the University of Ottawa.  He holds his Diplomate, Clinical Chemistry, American Board of Clinical Chemists and is a Fellow of the US National Academy of Clinical Biochemistry and the Canadian Academy of Clinical Biochemistry.